查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1198776

語音假體設備市場 - 增長、趨勢、COVID-19 影響和預測 (2023-2028)

Voice Prosthesis Devices Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 115 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計在預測期內（2022-2027 年），語音假肢設備市場的複合年增長率為 5.6%。

COVID-19 爆發導致臨床操作延誤。這會在一定程度上影響市場增長。例如，根據 Smith & Nephew 於 2021 年 6 月發布的年度報告，ENT（耳鼻喉）設備公司，包括 Smith & Nephew 和 Cochlear Limited 等主要參與者，都經歷了臨床試驗延遲。去年 COVID-19 影響了 ENT（耳鼻喉）設備市場，正如美國國家醫學圖書館在 2020 年 8 月發布的題為“COVID-19 流行病對耳鼻喉手術量的影響”所公佈的那樣，共有 2840 萬台手術已經完成在為期 12 週的 COVID-19 激增期間被推遲或取消。其中，230 萬與癌症治療或診斷有關。另一方面，良性疾病、骨科手術和耳鼻喉科的病例最常被推遲或取消。銷售額下降主要是由於 COVID-19 的影響推遲了耳鼻喉科和骨盆矯形器。大流行前 2020 年的銷售是由耳鼻喉手術導航系統、術中 NIM 神經監測系統和動力耳鼻喉儀器的固定設備銷售推動的。因此，COVID-19 對市場增長產生了重大影響。

推動語音假體設備市場增長的主要因素是導致喉嚨痛和耳痛的喉癌患者的全球患病率上升。

例如，根據NIDCD（National Institute on Deafness and Other Communication Disorders） 2020 年的更新，美國約有 750 萬人患有與聲音相關的問題。此外，政府增加醫療保健支出以及製造商定制假體發聲設備尺寸以提高患者依從性、減少說話費力和有效發揮功能的研發活動導致假體發聲設備的增加。它將激活世界市場。

除此之外，語音假體設備市場受到喉癌病例數量增加的推動。喉癌是一種在喉部組織中形成癌細胞並導致喉嚨痛和耳痛的疾病。根據 2022 年 2 月的 Cancer.net 更新，喉癌是一種眾所周知的頭頸癌。到 2022 年，美國估計將有 12,470 名成年人（9,820 名男性和 2,650 名女性）被診斷出患有喉癌。這種疾病的流行率每年以大約 2% 到 3% 的速度下降。

此外，Atos 將於 2021 年 7 月成立 Heimomed Heinze GmbH & Co.KG，這是一家生產高質量氣管切開產品的醫療技術公司。通過此次收購，Atos 擴大了其在德國和奧地利的業務並支持市場增長。此外，2021 年 10 月，Freudenberg Medical 推出了革命性的免說話 HME 閥，用於喉切除術護理。

然而，非常高的製造設備成本、發音假體設備的高價格以及設備的短壽命（大約 3-6 個月）可能會阻礙發音假體設備市場的增長。

人工耳蝸市場趨勢

植入式語音修復設備市場預計將在預測期內佔據主要份額

在人工發音設備市場中，家用人工發音領域有望佔據較大份額。該行業的增長受到人口老齡化和技術進步的推動，這些技術進步使設備功能更加高效，包括更長的預期壽命、更好的患者對手術的依從性以及包括門診更換在內的維護。此外，由於它具有低空氣阻力並且可以最佳地附著在氣管食管壁上，因此越來越多地選擇留置人工聲帶，這有助於增加人工聲帶的全球市場份額。

醫療技術公司已經為喉切除術後的成年人提供內置人工語音，以實現口頭交流並取得高臨床療效。留置發聲假體已獲得臨床認可，可用於患者的發聲康復，尤其是喉癌和下嚥癌患者。

例如，根據 2020 年 2 月發表的一項題為“喉癌流行病學更新”的研究，目前喉癌的發病率和患病率分別為每 10 萬人 2.76 例/年，估計為每 10 萬人 14.33 例/年人口，平均每年 328 萬殘疾調整生命年。在過去 30 年中，發病率和患病率分別增加了 12% 和 24%。此外，根據 GLOBOCAN 於 2020 年更新的統計數據，2020 年喉癌新發病例數為 185,000 例，預計到 2040 年將增至 284,000 例。因此，全球喉癌病例數量的增加正在推動對內置語音助聽器的需求，預計這將在預測期內進一步加速該細分市場的增長。

此外，根據 2022 年 3 月發表的一項題為“印度喉切除者的語音假體體驗”的研究。根據 2022 年 3 月發表的一項題為“印度南部一家三級醫院的初步調查結果”的研究，此外，非集成和集成語音假體之間的成本差異是選擇語音假體的主要驅動力。。因此，由於留置人工耳蝸的主導地位，預計該細分市場將在預測期內擴大。

預計對語音修復設備的需求不斷增長將有助於留置語音修復設備細分市場的增長。留置式語音助聽器因其技術簡單而需求量很大，可提高語音質量和患者滿意度。

因此，由於上述因素，研究部門有望為市場的顯著增長做出貢獻。

北美主導語音假體設備市場，預計在預測期內也會如此

在整個預測期內，北美預計將主導整個 VPD 市場。這一優勢主要歸因於氣管切開術癌症發病率的增加、醫療保健支出的增加以及先進醫療保健基礎設施的可用性。例如，根據美國癌症協會2022年1月的最新估計，2022年美國約有12470例喉癌新發病例，其中男性9820例，女性2650例。此外，根據GLOBOCAN 2020年更新的統計數據，2020年美國將新增12600例喉癌病例，預計到2040年美國將增加至最多15700例。因此，該地區喉癌病例的增加預計會增加語音修復設備的採用。因此，預計該地區在預測期內將經歷快速的市場擴張。

此外，正在進行多種類型的研究活動，各種公共和私人研究機構正在與製造商合作，這有望推動語音假體市場。

因此，由於上述因素，預計所研究的市場將導致北美市場的利潤豐厚的增長。

發聲器市場競爭者分析

全球語音假肢市場競爭適中，由幾家主要參與者組成。目前在市場份額方面佔據市場主導地位的一些知名企業已與其他公司建立合作夥伴關係，以獲取產品並加強其在全球的市場地位，而其他公司則在分銷產品。目前主導市場的公司包括 Andreas Fahl Medizintechnik-Vertrieb GmbH、InHealth Technologies、Atos Medical AB、Servona GmbH、Teleflex Incorporated 和 Smiths Medical。

其他福利

  • Excel 格式的市場預測 (ME) 表
  • 3 個月的分析師支持

目錄

第 1 章 簡介

  • 研究假設和市場定義
  • 調查範圍

第二章研究方法論

第三章執行摘要

第四章市場動態

  • 市場概況
  • 市場驅動力
    • 老年人口增加和醫療報銷增加
    • 由於癌症患者的增加，對語音假體的需求增加
  • 市場製約因素
    • 語音修復設備的高采購和維護成本
    • 設備壽命短，缺乏患者可用性和接受度
  • 波特五力分析
    • 新進入者的威脅
    • 買方議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭對手之間的競爭

第 5 章市場細分（基於價值的市場規模：百萬美元）

  • 按設備
    • 非植入式人工發音裝置
    • 植入式人工發音裝置
  • 按最終用戶
    • 醫院
    • 診所
    • 其他
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 歐洲其他地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 亞太其他地區
  • 世界其他地區

第六章競爭格局

  • 公司簡介
    • Andreas Fahl Medical Technology Sales GmbH
    • InHealth Technologies
    • Atos Medical AB
    • Servona GmbH
    • ICU Medical Inc（Smiths Medical）
    • Teleflex Incorporated
    • HEIMOMED Heinze
    • Hood Laboratories
    • Karl Storz Gmbh & Co. Kg

第七章市場機會與未來趨勢

簡介目錄
Product Code: 67694

The voice prosthesis devices market is projected to register a CAGR of 5.6% during the forecast period (2022 - 2027).

The outbreak of COVID-19 had led to delays in clinical operations. This can impact the market growth to a certain extent. For instance, as per the annual report of Smith & Nephew published in June 2021 ENT (Ear, Nose, Throat) device companies, including major players, such as Smith & Nephew and Cochlear Limited, saw clinical trial delays. As per the National Library of Medicine in August 2020, titled "Impact of the COVID-19 epidemic on ENT surgical volume" COVID-19 had an impact on the ENT (Ear, Nose, Throat) devices market last year, with a total of 28.4 million operations have been postponed or canceled during the 12-week COVID-19 surge. Of these cases, 2.3 million were related to cancer treatment or diagnosis. The case types that were most likely to be postponed or delayed were those related to benign diseases, orthopedic, or ENT (Ear, Nose, Throat). The net sales witnessed a decline, which was primarily caused by the postponed procedures across both ENT and Pelvic Health, as a result of COVID-19. Before the pandemic's impact, the fiscal year 2020 sales were driven by capital equipment sales of the ENT surgical navigation system, intraoperative NIM nerve monitoring system, and powered ENT instruments. Thus, COVID-19 had a significant impact on the growth of the market.

The major factors attributing to the growth of the Voice Prosthesis Devices market are the rise in the global prevalence of larynx cancer cases which results in sore throat and ear pain.

For instance, according to the NIDCD (National Institute on Deafness and Other Communication Disorders) updated in 2020, about 7.5 million people in the United States suffered from voice-related problems. Also, the increase in government expenditure for healthcare, and R&D activities by the manufacturers to customize the Voice Prosthesis Devices size to enhance patient compliance, lesser effort to speak and efficient functioning will fuel the global Voice Prosthesis Devices market.

In addition to this, the voice prosthesis device and equipment market is driven by an increasing number of cases of larynx cancer. Larynx cancer is a disease in which cancer cells form tissue in the larynx and cause a sore throat and ear pain. As per Cancer.net updates from February 2022, laryngeal cancer is a common type of head and neck cancer. In 2022, an estimated 12,470 adults (9,820 men and 2,650 women) in the United States will be diagnosed with laryngeal cancer. The incidence rates of this disease are decreasing by around 2% to 3% annually.

Moreover, in July 2021, Atos acquired Heimomed Heinze GmbH & Co. KG, a med-tech company that manufactures high-quality tracheostomy products. With this acquisition, Atos expands its footprint in Germany and Austria, thus fueling the market growth. Additionally, in October 2021, Freudenberg Medical Launched Breakthrough SpeakFree HME Valve for Laryngectomy Care.

However, highly expensive equipment for manufacture, prices of voice prosthesis devices, and shorter life span of the devices only about 3-6 months are likely to impede the voice prosthesis devices market growth.

Voice Prosthesis Devices Market Trends

In-Dwelling Voice Prosthesis Devices Segment is Expected to Hold the Major Market Share Over the Forecast Period

The in-dwelling voice prosthesis devices segment is expected to account for a large share of the voice prosthesis devices market. The growth of the segment can be attributed to the rising geriatric population and technological advancements which enhanced the efficiency of device functioning such as prolonged lifetime, and improved patient compliance to operating, and maintenance including outpatient replacements. Also, due to their ability to have low air resistance and optimal retention in the tracheoesophageal wall, the preference for the Indwelling voice prosthesis devices has been increased and thus, contributes to their share in the global voice prosthesis devices market.

Medical technology companies have been offering indwelling voice prostheses for adults following the total laryngectomy to enable them to communicate verbally with high clinical outcomes. in-dwelling voice prosthesis devices are gaining clinical acceptance for speech rehabilitation in patients, especially in patients with laryngeal and hypopharyngeal cancer.

For instance, as per the study published in February 2020, titled "Updates on larynx cancer epidemiology", the current incidence and prevalence of laryngeal cancer are estimated at 2.76 cases/year per 100,000 inhabitants, and 14.33 cases/year per 100,000 inhabitants, respectively, averaging 3.28 million DALYs each year. Incidence and prevalence have increased by 12% and 24%, respectively during the past 3 decades. Furthermore, as per the statistics updated in 2020 by the GLOBOCAN the estimated number of new cases of Laryngeal cancer was 185,000 in 2020 which is expected to increase and reach up to 284,000 by 2040 globally. Thus, the increasing cases of laryngeal cancer worldwide are expected to increase the demand for in-dwelling voice prosthesis devices which will further surge the growth of the segment over the forecast period.

Additionally, as per the study published in March 2022, titled "Voice prosthesis experience of Indian laryngectomees: Preliminary findings from a tertiary hospital in South India", besides, the difference in the cost between nonindwelling and indwelling voice prostheses is a major driving factor in opting for it. Thus, due to the advantage offered by the in-dwelling voice prosthesis device, the market segment is expected to increase over the forecast period.

The rise in demand for voice prosthesis devices is likely to contribute to the growth of the indwelling voice prosthesis device segments. Demand for indwelling voice prosthesis devices is high due to their technical simplicity, leading to improvement in voice quality and patient satisfaction.

Thus, due to the above-mentioned factors, the studied segment is expected to contribute to the significant growth of the market.

North America Dominates the Voice Prosthesis Devices Market and Expected to do Same in the Forecast Period.

North America is expected to dominate the overall VPD market throughout the forecast period. This dominance is mainly owing to the increased incidence of tracheostomy cancers along with the increased healthcare expenditure and availability of advanced healthcare infrastructure. For instance, the American Cancer Society's most recent January 2022, estimates for laryngeal cancer in the United States in 2022, about 12,470 new cases of laryngeal cancer are estimated to be 9,820 in men and 2,650 in women. Furthermore, as per the statistics updated in 2020 by the GLOBOCAN, the estimated number of new cases of Laryngeal cancer was 12,600 in 2020 which is expected to increase and reach up to 15,700 by 2040 in the United States. Thus the increase in laryngeal cancer cases in the region is expected to increase the adoption of voice prosthesis devices. Thereby, the market is expected to surge in the region over the forecast period.

Furthermore, several types of research activities are going on and various public and private research institutes collaborated with the manufacturers, which is expected to drive the voice prosthesis devices market.

Therefore, due to the above-mentioned factors, the studied market is expected to lead to lucrative growth of the market in North America.

Voice Prosthesis Devices Market Competitor Analysis

The global voice prosthesis devices market is moderately competitive and consists of several major players. Some prominent players that are currently dominating the market In terms of market share are acquiring the products, entering into partnerships with the other companies to consolidate their market positions across the globe and while others are distributing products. Some of the companies which are currently dominating the market are Andreas Fahl Medizintechnik-Vertrieb GmbH, InHealth Technologies, Atos Medical AB, Servona GmbH, Teleflex Incorporated, and Smiths Medical.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions & Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rapidly Growing Geriatric Population along with Rise in Healthcare Reimbursements
    • 4.2.2 Increasing Demand for Voice Prosthetics with Rise in Cancer Cases
  • 4.3 Market Restraints
    • 4.3.1 High Procurement and Maintenance Costs of Voice Prosthesis Devices
    • 4.3.2 Shorter Lifespan of the Devices along with Lack of Availability and Acceptance by the Patients
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Devices
    • 5.1.1 Non-dwelling Voice Prosthesis Devices
    • 5.1.2 In-dwelling Voice Prosthesis Devices
  • 5.2 By End User
    • 5.2.1 Hospitals
    • 5.2.2 Clinics
    • 5.2.3 Others
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
  • 5.4 Rest of the World

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Andreas Fahl Medical Technology Sales GmbH
    • 6.1.2 InHealth Technologies
    • 6.1.3 Atos Medical AB
    • 6.1.4 Servona GmbH
    • 6.1.5 ICU Medical Inc (Smiths Medical)
    • 6.1.6 Teleflex Incorporated
    • 6.1.7 HEIMOMED Heinze
    • 6.1.8 Hood Laboratories
    • 6.1.9 Karl Storz Gmbh & Co. Kg

7 MARKET OPPORTUNITIES AND FUTURE TRENDS